✦ LIBER ✦

PSS19 A PHARMACOECONOMIC EVALUATION OF PEGAPTANIB FOR THE MANAGEMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) IN MEXICO

✍ Scribed by GY Vega-Hernández; J Idrovo-Velandia; R Rivas; L Zapata; J Venegas; H Ramírez; J Mould-Ouevedo; G Davila-Loaiza

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSS25 PHARMACOECONOMIC STUDY OF WET AGE-

✍ IF Soria-Cedillo; JL Robledo; E Carrazana; F Garcia-Contreras 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PSS26 PHARMACOECONOMIC EVALUATION OF RAN

✍ E Walter; C Brennig; K Moeremans; V Thomas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTA

✍ LY Lu; W McGhan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Pegaptanib sodium for the treatment of n

✍ Helen Kourlas; Daryl S. Schiller 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 825 KB

Evaluation of a reading rehabilitation p

✍ Gary S. Rubin; Mary Feely 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB

PSS10 COST-EFFECTIVENESS OF ANTIVEGF THE

✍ RLP Bueno; E Lion 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB